Explorer
Subject Expert Committee
India
Bharat Biotech Asked For More Data By DCGI For Authorising Covaxin To Children Under 12
India
SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years
India
Biological E Applies For EUA For Covid-19 Vaccine Corbevax For 5-12 Age Group: Report
Health
Amid Omicron Fear, Expert Committee Gives No Recommendations For COVID Booster Dose: Report
India
CDSCO Expert Panel Recommends Emergency Use Of Covaxin For Children Aged Between 2-18
Health
Bharat Biotech Gets Approval To Start Next Phase Of Clinical Trials Of 'Covaxin' On Children Aged 2-18 Years
India
Expert Panel Gives Nod To Bharat Biotech’s Covaxin For Restricted Emergency Use
Advertisement
Advertisement
























